EUIPO trademark

NURALOGIX

RegisteredEUIPOWord markClass 9Class 10Class 35Class 42+1

"NURALOGIX" is a word mark owned by Nuralogix Corporation, filed at the EUIPO on August 28, 2020. It is registered and covers classes 9, 10, 35, 42 and 44.

Official EUIPO record
NURALOGIX
Word mark as filed with the EUIPO
Status
Registered
Since March 17, 2021
Filed
August 28, 2020
Registered
March 13, 2021
Expires
August 28, 2030
Application no.
018297611
Registration no.
018297611
Office
EUIPO
European Union Intellectual Property Office
Mark type
Word mark
5 classes
Ownership

Who owns NURALOGIX

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services NURALOGIX is filed for, grouped by Nice class.

  • Downloadable computer software for use in providing healthcare information; downloadable computer software for providing medical information; downloadable computer software for health assessment; downloadable computer software for medical information, namely reporting and interpreting health care data; downloadable computer software for use in measurement of biometric data; downloadable computer software for determining human health data, namely blood flow, blood pressure, heart rate, physiological activity, physiological stress, psychological markers, emotional health; downloadable computer software for use in contactless health data determination; downloadable computer software for use in predicting health risks; downloadable computer software for use in analyzing hemoglobin concentration; downloadable computer software for use in accessing and reviewing health data; downloadable computer software for use in detecting health abnormalities; downloadable applications for handheld computers, wearable computers, laptop computers, desktop computers, and mobile phones for physiological signal measurement; downloadable computer software for providing health self-assessment

  • Devices for measuring biometric data, namely blood flow, blood pressure, heart rate, physiological activity, physiological stress, psychological markers, emotional health; devices for non-invasive determination of biometric data; devices for analyzing hemoglobin concentration; devices for detecting health abnormalities

  • Electronic processing of health care information

  • Software as a service (SAAS) services featuring software for use in providing healthcare information; Software as a service (SAAS) services featuring software for providing medical information; Software as a service (SAAS) services featuring software for health assessment; Software as a service (SAAS) services featuring software for medical information, namely reporting and interpreting health care data; Software as a service (SAAS) services featuring software for use in measurement of biometric data; Software as a service (SAAS) services featuring software for determining human health data, namely blood flow, blood pressure, heart rate, physiological activity, physiological stress, psychological markers, emotional health; Software as a service (SAAS) services featuring software for use in contactless health data determination; Software as a service (SAAS) services featuring software for use in predicting health risks; Software as a service (SAAS) services featuring software for use in analyzing hemoglobin concentration; Software as a service (SAAS) services featuring software for use in accessing and reviewing health data; Software as a service (SAAS) services featuring software for use in detecting health abnormalities; Software as a service (SAAS) services featuring software for providing health self-assessment

  • Providing medical information; providing healthcare information; medical screening services; health assessment services; medical diagnostic testing, monitoring and reporting services; medical information services, namely reporting and interpreting health care results; provision of medical information related to blood flow, blood pressure, heart rate, physiological activity, physiological stress, psychological markers, emotional health; providing healthcare information from image analysis; providing information in the field of healthcare

History

What has happened so far

Steps recorded by the EUIPO, newest first.

  1. Bulletin 2021/051 Section B.1
  2. Bulletin 2020/232 Section A.1
FAQ

About NURALOGIX

Who owns the trademark "NURALOGIX"?

The EUIPO trademark "NURALOGIX" (application 018297611) is owned by Nuralogix Corporation.

What is the status of "NURALOGIX"?

Its status at the EUIPO is: registered.

When was "NURALOGIX" registered?

It was registered on March 13, 2021 and is due to expire on August 28, 2030.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull NURALOGIX and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019d4321-d2df-75d6-ad87-1e922cd48de7
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d4321-d2df-75d6-ad87-1e922cd48de7",
  "object": "trademark",
  "mark_text": "NURALOGIX",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "EM",
  "application_number": "018297611",
  "filing_date": "2020-08-28",
  "nice_classes": [
    9,
    10,
    35,
    42,
    44
  ],
  "owners": [
    {
      "name": "NURALOGIX CORPORATION",
      "entity_id": "ent_019eb7e0-e2de-721d-87e9-965a657c53e1"
    }
  ]
}